DRAIOCHT A low cost minimally invasive platform medical device for the treatmen...
DRAIOCHT A low cost minimally invasive platform medical device for the treatment of disorders of the cardiovascular system.
Microwave ablation produces a small and highly controllable heating zone, ideal for the thermal treatment of a range of medical conditions where damage to adjacent structures is a significant risk.
Potential applications range fro...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
RTC-2016-5445-1
ABLAVIEW - Un Sistema Innovador de Ablación por Radio-Frecue...
584K€
Cerrado
NIMBLE WOMENTECHEU
A novel non-invasive and non-ionizing medical device for mon...
75K€
Cerrado
NIMBLE System
"The NIMBLE System: A novel non-invasive and non-ionizing me...
3M€
Cerrado
ENDOWAVE
ENDObronchial microWAVE Ablation for the minimally invasive...
71K€
Cerrado
FIBERSTAR
FIBER optic sensors for Smart Thermal Ablation at Radiofrequ...
158K€
Cerrado
Información proyecto DRAIOCHT
Duración del proyecto: 19 meses
Fecha Inicio: 2018-05-08
Fecha Fin: 2019-12-31
Líder del proyecto
UNIVERSITY OF GALWAY
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
130K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Microwave ablation produces a small and highly controllable heating zone, ideal for the thermal treatment of a range of medical conditions where damage to adjacent structures is a significant risk.
Potential applications range from the treatment of small soft-tissue cancers to the management of various venous disorders. The DRAIOCHT project will involve the design, development and pre-clinical evaluation of a novel microwave ablation device for the treatment of disorders of the venous system. The proposed device will provide a new low cost therapeutic medical device, that places greater value on the protection of crucial functional tissue and nerves compared to current ablation devices on the market. The project is of significant economic and societal benefits due to the high prevalence of venous diseases in Europe.